SCHEMBL20722883

SCHEMBL20722883

O=C(O)NC1C(=O)N(Cc2ccccc2)CC1CF

nearest known ligand 0.49

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
▸ CCKBR P32239 2/20 0.47
▸ SIRT5 Q9NXA8 1/20 0.43
▸ SMN1; SMN2 Q16637 1/20 0.40
▸ KMT2A Q03164 3/20 0.40
▸ POLB P06746 1/20 0.40
▸ CYP2D6 P10635 1/20 0.40
▸ CYP2C9 P11712 1/20 0.40
▸ CYP2C19 P33261 1/20 0.40
▸ BRD4 O60885 1/20 0.39
▸ HPGD P15428 1/20 0.39
▸ TSHR P16473 1/20 0.39
▸ GAA P10253 2/20 0.39
▸ MEN1 O00255 1/20 0.39
▸ ALDH1A1 P00352 1/20 0.39
▸ MTNR1A P48039 1/20 0.39
▸ MTNR1B P49286 1/20 0.39
▸ PKM P14618 1/20 0.39
▸ PREP P48147 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21685914 0.84 KMT2A (0.49) CCKBRSIRT5KMT2ATSHRMEN1
SCHEMBL20722497 0.84 KMT2A (0.49) CCKBRSIRT5KMT2ATSHRMEN1
SCHEMBL20722523 0.79 KMT2A (0.50) SIRT5KMT2APOLBCYP2D6CYP2C9
SCHEMBL20722526 0.79 KMT2A (0.50) SIRT5KMT2APOLBCYP2D6CYP2C9
SCHEMBL20722524 0.79 KMT2A (0.50) SIRT5KMT2APOLBCYP2D6CYP2C9
SCHEMBL28568885 0.75 SIRT5 (0.45) CCKBRSIRT5SMN1; SMN2KMT2ABRD4
SCHEMBL20722821 0.73 S1PR5 (0.47) KMT2APOLB
SCHEMBL6073067 0.72 KDM4E (0.45) CCKBRSIRT5SMN1; SMN2KMT2APOLB
SCHEMBL23938197 0.70 HPGD (0.38) SIRT5KMT2ABRD4HPGDTSHR
SCHEMBL21685014 0.70 HPGD (0.38) SIRT5KMT2ABRD4HPGDTSHR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3665169-A1 CARBOXAMIDES AS UBIQUITIN-SPECIFIC PROTEASE INHIBITORS Forma Therapeutics, Inc. (US) 2020-06-17 — — EP disclosed
WO-2019032863-A1 CARBOXAMIDES AS UBIQUITIN-SPECIFIC PROTEASE INHIBITORS FORMA THERAPEUTICS, INC. (US) 2019-02-14 — — WO disclosed
Send feedback